Adoptive transfer
material combination stepProtocol: Phase I clinical trial protocol in patients with advanced (stage III or IV) melanoma
The primary objective of this trial is to determine toxicity and feasibility of treatment of patients with advanced melanoma with DC vaccine and adoptive transfer.
created over 16 years ago (2 March 2009) last modified over 13 years ago (28 September 2011)  [ RDF ]  [ RelFinder ]